TCR2 Therapeutics saw the highest growth of 99% in patent filings and 199% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 99% and grants by 199%. GlobalData’s DataBook provides a comprehensive analysis of TCR2 Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

TCR2 Therapeutics has been focused on protecting inventions in European Patent Office(EPO) with two publications in Q4 2023

The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 25% filings and 0% grants. The European Patent Office(EPO), Denmark(DK), United States(US), and Israel(IL) patent Office are among the top ten patent offices where TCR2 Therapeutics is filings its patents. Among the top granted patent authorities, TCR2 Therapeutics has 67% of its grants in Israel(IL) and 33% in Poland(PL).

Patents related to rare diseases lead TCR2 Therapeutics's portfolio

TCR2 Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q4 2023.

Multiple sclerosis related patents lead TCR2 Therapeutics portfolio followed by polyradiculoneuropathy, and celiac disease

TCR2 Therapeutics has highest number of patents in multiple sclerosis followed by polyradiculoneuropathy, celiac disease, acquired (autoimmune) hemolytic anemia, and inflammation.

For comprehensive analysis of TCR2 Therapeutics's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.